Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Vandenberg

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Breast Cancer Research and Treatment|April 27, 2007
A Phase 2 study of perifosine in advanced or metastatic breast cancerNatasha B Leighl, Susan Dent, Mark Clemons, et al.
Chemical Science|February 29, 2020
Novel four-disulfide insulin analog with high aggregation stability and potencyXiaochun Xiong, Alan Blakely, Prasoona Karra, et al.
The New England Journal of Medicine|August 3, 2012
Combination anastrozole and fulvestrant in metastatic breast cancerRita S Mehta, William E Barlow, Kathy S Albain, et al.
Breast Cancer Research and Treatment|April 13, 2013
CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapyWendy A Teft, Inna Y Gong, Brian Dingle, et al.
Oncology (Williston Park, N.Y.)|August 1, 1997
Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancerJ M Nabholtz, B Thuerlimann, W R Bezwoda, et al.
The New England Journal of Medicine|March 28, 2019
Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast CancerRita S Mehta, William E Barlow, Kathy S Albain, et al.
World Journal of Clinical Oncology|December 11, 2014
Competing risks of death in younger and older postmenopausal breast cancer patientsJudy-Anne W Chapman, Kathleen I Pritchard, Paul E Goss, et al.
Clinical Biochemistry|August 4, 2015
Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNAPatricia Valda Toro, Bracha Erlanger, Julia A Beaver, et al.
British Journal of Clinical Pharmacology|February 10, 2016
Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226Daniel L Hertz, William E Barlow, Kelley M Kidwell, et al.
Breast Cancer Research and Treatment|July 8, 2020
Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patientsAdrienne E Borrie, Finnley A Rose, Yun-Hee Choi, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Breast Cancer Research and Treatment|April 27, 2007
A Phase 2 study of perifosine in advanced or metastatic breast cancerNatasha B Leighl, Susan Dent, Mark Clemons, et al.
Chemical Science|February 29, 2020
Novel four-disulfide insulin analog with high aggregation stability and potencyXiaochun Xiong, Alan Blakely, Prasoona Karra, et al.
The New England Journal of Medicine|August 3, 2012
Combination anastrozole and fulvestrant in metastatic breast cancerRita S Mehta, William E Barlow, Kathy S Albain, et al.
Breast Cancer Research and Treatment|April 13, 2013
CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapyWendy A Teft, Inna Y Gong, Brian Dingle, et al.
Oncology (Williston Park, N.Y.)|August 1, 1997
Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancerJ M Nabholtz, B Thuerlimann, W R Bezwoda, et al.
The New England Journal of Medicine|March 28, 2019
Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast CancerRita S Mehta, William E Barlow, Kathy S Albain, et al.
World Journal of Clinical Oncology|December 11, 2014
Competing risks of death in younger and older postmenopausal breast cancer patientsJudy-Anne W Chapman, Kathleen I Pritchard, Paul E Goss, et al.
Clinical Biochemistry|August 4, 2015
Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNAPatricia Valda Toro, Bracha Erlanger, Julia A Beaver, et al.
British Journal of Clinical Pharmacology|February 10, 2016
Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226Daniel L Hertz, William E Barlow, Kelley M Kidwell, et al.
Breast Cancer Research and Treatment|July 8, 2020
Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patientsAdrienne E Borrie, Finnley A Rose, Yun-Hee Choi, et al.
Pageof 12